Clinical Trial Update: A Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of HRS-4508 Monotherapy in Patients With Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical study overview evaluating HRS-4508 monotherapy in patients with advanced or metastatic solid tumors, focusing on safety, tolerability…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• HRS-4508

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: NOT_YET_RECRUITING